These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17650835)

  • 1. Increased frequency of large local reactions among systemic reactors during subcutaneous allergen immunotherapy.
    Roy SR; Sigmon JR; Olivier J; Moffitt JE; Brown DA; Marshall GD
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):82-6. PubMed ID: 17650835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
    Kelso JM
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local reactions during allergen immunotherapy do not require dose adjustment.
    Tankersley MS; Butler KK; Butler WK; Goetz DW
    J Allergy Clin Immunol; 2000 Nov; 106(5):840-3. PubMed ID: 11080704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions regarding local reactions from allergen immunotherapy injections.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):96-100. PubMed ID: 18681091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic reactions with aeroallergen cluster immunotherapy in a clinical practice.
    Copenhaver CC; Parker A; Patch S
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):441-7. PubMed ID: 22018617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The REPEAT study: recognizing and evaluating periodic local reactions in allergen immunotherapy and associated systemic reactions.
    Calabria CW; Stolfi A; Tankersley MS
    Ann Allergy Asthma Immunol; 2011 Jan; 106(1):49-53. PubMed ID: 21195945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side-effects of injective allergen immunotherapy administered to intermittent or persistent allergic rhinitis patients.
    Rogala B; Markiewicz-Bendkowska IB; Brzoza Z; Glück J; Oleś E
    Rhinology; 2007 Jun; 45(2):134-9. PubMed ID: 17708460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study.
    Confino-Cohen R; Goldberg A
    Ann Allergy Asthma Immunol; 2010 Jan; 104(1):73-8. PubMed ID: 20143649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy.
    Lin MS; Tanner E; Lynn J; Friday GA
    Ann Allergy; 1993 Dec; 71(6):557-62. PubMed ID: 8267250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local reactions from subcutaneous allergen immunotherapy.
    Coop CA
    Immunotherapy; 2013 Dec; 5(12):1339-45. PubMed ID: 24283844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors.
    Rank MA; Oslie CL; Krogman JL; Park MA; Li JT
    Allergy Asthma Proc; 2008; 29(4):400-5. PubMed ID: 18702889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imported fire ant field reaction and immunotherapy safety characteristics: the IFACS study.
    La Shell MS; Calabria CW; Quinn JM
    J Allergy Clin Immunol; 2010 Jun; 125(6):1294-9. PubMed ID: 20451988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal immunotherapy in patients with allergic fungal sinusitis.
    Greenhaw B; deShazo RD; Arnold J; Wright L
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting compliance with allergen immunotherapy at a military medical center.
    More DR; Hagan LL
    Ann Allergy Asthma Immunol; 2002 Apr; 88(4):391-4. PubMed ID: 11991556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GILL study: glycerin-induced local reactions in immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):222-6. PubMed ID: 17919703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009.
    Robertson BD; McCoy RL; Nelson MR; Haymore BR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):437-40. PubMed ID: 22018616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.